AIM IMMUNOTECH INC. Property, Plant, and Equipment, Fair Value Disclosure
AIM IMMUNOTECH INC. (AIM) had Property, Plant, and Equipment, Fair Value Disclosure of $3.90 million as of 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:PropertyPlantAndEquipmentFairValueDisclosure · last filed 2023-03-31
- 2021-12-31: Property, Plant, and Equipment, Fair Value Disclosure $3.90M.
| Period end | Property, Plant, and Equipment, Fair Value Disclosure |
|---|---|
| 2021-12-31 | $3.90M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |